Research Paper Volume 15, Issue 4 pp 1210—1227
Inhibition of apoptosis through AKT-mTOR pathway in ovarian cancer and renal cancer
Figure 9. Survival analysis, forest map. (A) NDUFS1: p = 0.36, HR = 0.83, 95% CI (0.56, 1.24); (B) NUF2: p = 0.62, HR = 0.90, 95% CI (0.60, 1.35); (C) PLK4: p = 0.10, HR = 1.41, 95% CI (0.94, 2.12); (D) PSMB2: p = 6.9e-4, HR = 0.50, 95% CI (0.33, 0.75); (E) PSME4: p = 0.32, HR = 1.23, 95% CI (0.82, 1.84); (F) TTK: p = 0.37, HR = 1.20, 95% CI (0.80, 1.79); (G) UBE2C: p = 0.37, HR = 0.83, 95% CI (0.56, 1.24); (H) YKT6: p = 0.27, HR = 0.80, 95% CI (0.53, 1.19).